Generalizable and Robust Deep Learning Algorithm for Atrial Fibrillation Diagnosis Across Ethnicities, Ages and Sexes
Authors:
Shany Biton,
Mohsin Aldhafeeri,
Erez Marcusohn,
Kenta Tsutsui,
Tom Szwagier,
Adi Elias,
Julien Oster,
Jean Marc Sellal,
Mahmoud Suleiman,
Joachim A. Behar
Abstract:
To drive health innovation that meets the needs of all and democratize healthcare, there is a need to assess the generalization performance of deep learning (DL) algorithms across various distribution shifts to ensure that these algorithms are robust. This retrospective study is, to the best of our knowledge, the first to develop and assess the generalization performance of a deep learning (DL) mo…
▽ More
To drive health innovation that meets the needs of all and democratize healthcare, there is a need to assess the generalization performance of deep learning (DL) algorithms across various distribution shifts to ensure that these algorithms are robust. This retrospective study is, to the best of our knowledge, the first to develop and assess the generalization performance of a deep learning (DL) model for AF events detection from long term beat-to-beat intervals across ethnicities, ages and sexes. The new recurrent DL model, denoted ArNet2, was developed on a large retrospective dataset of 2,147 patients totaling 51,386 hours of continuous electrocardiogram (ECG). The models generalization was evaluated on manually annotated test sets from four centers (USA, Israel, Japan and China) totaling 402 patients. The model was further validated on a retrospective dataset of 1,730 consecutives Holter recordings from the Rambam Hospital Holter clinic, Haifa, Israel. The model outperformed benchmark state-of-the-art models and generalized well across ethnicities, ages and sexes. Performance was higher for female than male and young adults (less than 60 years old) and showed some differences across ethnicities. The main finding explaining these variations was an impairment in performance in groups with a higher prevalence of atrial flutter (AFL). Our findings on the relative performance of ArNet2 across groups may have clinical implications on the choice of the preferred AF examination method to use relative to the group of interest.
△ Less
Submitted 20 July, 2022;
originally announced July 2022.
